Literature DB >> 15163498

The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses.

Sang Heui Seo1, Erich Hoffmann, Robert G Webster.   

Abstract

The H5N1 influenza viruses transmitted to humans in 1997 were highly virulent, but the mechanism of their virulence in humans is largely unknown. Here we show that lethal H5N1 influenza viruses, unlike other human, avian, and swine influenza viruses, are resistant to the anti-viral effects of interferons and tumor necrosis factor alpha The nonstructural (NS) gene of H5N1 viruses is associated with this resistance. Pigs infected with recombinant human H1N1 influenza virus that carried the H5N1 NS gene experienced significantly greater and more prolonged viremia, fever, and weight loss than did pigs infected with wild-type human H1N1 influenza virus. These effects required the presence of glutamic acid at position 92 of the NS1 molecule. These findings may explain the mechanism of the high virulence of H5N1 influenza viruses in humans and provide insight into the virulence of 1918 Spanish influenza.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163498     DOI: 10.1016/j.virusres.2004.02.022

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  66 in total

1.  Variability is its specialty. Influenza vaccine shortages and the spectre of an avian influenza epidemic.

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2005-01       Impact factor: 8.807

Review 2.  The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-04       Impact factor: 3.402

Review 3.  The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-12       Impact factor: 3.402

4.  Homology modeling and examination of the effect of the D92E mutation on the H5N1 nonstructural protein NS1 effector domain.

Authors:  Minyong Li; Binghe Wang
Journal:  J Mol Model       Date:  2007-10-05       Impact factor: 1.810

5.  Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication.

Authors:  Jeffrey E McLean; Emmanuel Datan; Demetrius Matassov; Zahra F Zakeri
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

6.  Evolution of an avian H5N1 influenza A virus escape mutant.

Authors:  Kamel M A Hassanin; Ahmed S Abdel-Moneim
Journal:  World J Virol       Date:  2013-11-12

7.  Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

8.  The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV.

Authors:  Wenjun Ma; Dominique Brenner; Zhongfang Wang; Bianca Dauber; Christina Ehrhardt; Katrin Högner; Susanne Herold; Stephan Ludwig; Thorsten Wolff; Kangzhen Yu; Jürgen A Richt; Oliver Planz; Stephan Pleschka
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Jessica A Belser; Hui Zeng; Hualan Chen; Yumiko Matsuoka; Suryaprakash Sambhara; David E Swayne; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Authors:  Neal Van Hoeven; Jessica A Belser; Kristy J Szretter; Hui Zeng; Peter Staeheli; David E Swayne; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.